A patient becomes excessively sedated during midazolam-fentanyl sedation for a dental procedure. Flumazenil 0.2 mg IV reverses the benzodiazepine component. What is the most important limitation of flumazenil in this setting?
- A It must be given as a continuous infusion at 1 mg/kg/hour
- B It has a longer duration than midazolam, causing oversedation on rebound
- C It reliably reverses all degrees of sedation including general anaesthesia
- D It does not reverse fentanyl-induced respiratory depression ✓
Explanation
Flumazenil is a competitive antagonist at the benzodiazepine site of the GABA-D receptor and has no action at opioid receptors, so opioid-induced respiratory depression persists and needs naloxone. Its elimination half-time is shorter than that of most benzodiazepines, so resedation can occur, which is the opposite of option B. It incompletely reverses deep sedation and is not infused at 1 mg/kg/hour.
Reference: Katzung's Basic and Clinical Pharmacology, 16th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.